Literature DB >> 34347214

S-adenosylmethionine induces mitochondrial dysfunction, permeability transition pore opening and redox imbalance in subcellular preparations of rat liver.

Bianca Seminotti1, Ana Cristina Roginski1, Ângela Zanatta1, Alexandre Umpierrez Amaral1,2, Thabata Fernandes1, Kaleb Pinto Spannenberger1, Lucas Henrique Rodrigues da Silva1, Rafael Teixeira Ribeiro1, Guilhian Leipnitz1,3, Moacir Wajner4,5,6.   

Abstract

S-adenosylmethionine (AdoMet) predominantly accumulates in tissues and biological fluids of patients affected by liver dysmethylating diseases, particularly glycine N-methyltransferase, S-adenosylhomocysteine hydrolase and adenosine kinase deficiencies, as well as in some hepatic mtDNA depletion syndromes, whose pathogenesis of liver dysfunction is still poorly established. Therefore, in the present work, we investigated the effects of S-adenosylmethionine (AdoMet) on mitochondrial functions and redox homeostasis in rat liver. AdoMet decreased mitochondrial membrane potential and Ca2+ retention capacity, and these effects were fully prevented by cyclosporin A and ADP, indicating mitochondrial permeability transition (mPT) induction. It was also verified that the thiol-alkylating agent NEM prevented AdoMet-induced ΔΨm dissipation, implying a role for thiol oxidation in the mPT pore opening. AdoMet also increased ROS production and provoked protein and lipid oxidation. Furthermore, AdoMet reduced GSH levels and the activities of aconitase and α-ketoglutarate dehydrogenase. Free radical scavengers attenuated AdoMet effects on lipid peroxidation and GSH levels, supporting a role of ROS in these effects. It is therefore presumed that disturbance of mitochondrial functions associated with mPT and redox unbalance may represent relevant pathomechanisms of liver damage provoked by AdoMet in disorders in which this metabolite accumulates.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dysmethylating liver diseases; Hepatic mtDNA depletion syndromes; Liver toxicity; Mitochondrial dysfunction; Redox status; S-adenosylmethionine

Mesh:

Substances:

Year:  2021        PMID: 34347214     DOI: 10.1007/s10863-021-09914-3

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  68 in total

1.  Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease.

Authors:  M Y Aksenov; W R Markesbery
Journal:  Neurosci Lett       Date:  2001-04-20       Impact factor: 3.046

2.  S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy.

Authors:  I Barić; M Cuk; K Fumić; O Vugrek; R H Allen; B Glenn; M Maradin; L Pazanin; I Pogribny; M Rados; V Sarnavka; A Schulze; S Stabler; C Wagner; S H Zeisel; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Safranine as a probe of the mitochondrial membrane potential.

Authors:  K E Akerman; M K Wikström
Journal:  FEBS Lett       Date:  1976-10-01       Impact factor: 4.124

4.  S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells.

Authors:  Eduardo Ansorena; Elena R García-Trevijano; Maria L Martínez-Chantar; Zong-Zhi Huang; Lixin Chen; José M Mato; Maria Iraburu; Shelly C Lu; Matías A Avila
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

5.  Glycine N -methyltransferase deficiency: a new patient with a novel mutation.

Authors:  P Augoustides-Savvopoulou; Z Luka; S Karyda; S P Stabler; R H Allen; K Patsiaoura; C Wagner; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Glycine N-Methyltransferase Deficiency: A Member of Dysmethylating Liver Disorders?

Authors:  Ivo Barić; Sahin Erdol; Halil Saglam; Mila Lovrić; Robert Belužić; Oliver Vugrek; Henk J Blom; Ksenija Fumić
Journal:  JIMD Rep       Date:  2016-05-21

7.  S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism.

Authors:  Ivo Baric; Ksenija Fumic; Byron Glenn; Mario Cuk; Andreas Schulze; James D Finkelstein; S Jill James; Vlatka Mejaski-Bosnjak; Leo Pazanin; Igor P Pogribny; Marko Rados; Vladimir Sarnavka; Mira Scukanec-Spoljar; Robert H Allen; Sally Stabler; Lidija Uzelac; Oliver Vugrek; Conrad Wagner; Steven Zeisel; S Harvey Mudd
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  A Turkish patient with novel AHCY variants and presumed diagnosis of S-adenosylhomocysteine hydrolase deficiency.

Authors:  Hasan Bas; Oguz Cilingir; Neslihan Tekin; Suzan Saylisoy; Beyhan Durak Aras; Elif Uzay; Ebru Erzurumluoglu Gokalp; Sevilhan Artan
Journal:  Am J Med Genet A       Date:  2020-01-20       Impact factor: 2.802

9.  S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation.

Authors:  Ainhoa Iglesias Ara; Meng Xia; Komal Ramani; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 10.  Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders.

Authors:  Ivo Barić; Christian Staufner; Persephone Augoustides-Savvopoulou; Yin-Hsiu Chien; Dries Dobbelaere; Sarah C Grünert; Thomas Opladen; Danijela Petković Ramadža; Bojana Rakić; Anna Wedell; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2016-09-26       Impact factor: 4.982

View more
  1 in total

Review 1.  Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis.

Authors:  Keda Yang; Fangming Cao; Yuchuan Xue; Lin Tao; Yue Zhu
Journal:  Front Physiol       Date:  2022-03-03       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.